SCHEMBL1990666

SCHEMBL1990666

COCC1CC(Cn2nc(C3=C(c4c[nH]c5sccc45)C(=O)NC3=O)c3ccccc32)CCN1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 5/20 0.43
PRKACA P17612 3/20 0.39
PRKACG P22612 3/20 0.39
PRKACB P22694 3/20 0.39
SIRT2 Q8IXJ6 1/20 0.38
PRKCB P05771 11/20 0.38
PRKCA P17252 11/20 0.38
PRKCG P05129 10/20 0.38
GSK3B P49841 10/20 0.38
PRKCD Q05655 7/20 0.38
KCNH2 Q12809 3/20 0.36
PRKCZ Q05513 4/20 0.36
PRKCH P24723 4/20 0.36
PRKCE Q02156 4/20 0.36
CAMK2B Q13554 3/20 0.36
CAMK2G Q13555 3/20 0.36
CAMK2A Q9UQM7 3/20 0.36
SRC P12931 2/20 0.36
KISS1R Q969F8 1/20 0.35
PIM1 P11309 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1994012 0.92 CAMK2D (0.41) CAMK2DPRKACAPRKACGPRKACBSIRT2
SCHEMBL1990843 0.91 CAMK2D (0.44) CAMK2DPRKACAPRKACGPRKACBSIRT2
SCHEMBL1992015 0.89 CAMK2D (0.44) CAMK2DPRKACAPRKACGPRKACBSIRT2
SCHEMBL1990609 0.87 CAMK2D (0.44) CAMK2DPRKACAPRKACGPRKACBSIRT2
SCHEMBL1992218 0.86 CAMK2D (0.49) CAMK2DPRKACAPRKACGPRKACBPRKCB
SCHEMBL1993567 0.86 CAMK2D (0.41) CAMK2DPRKACAPRKACGPRKACBPRKCB
SCHEMBL1992095 0.86 CAMK2D (0.43) CAMK2DPRKACAPRKACGPRKACBSIRT2
SCHEMBL1997155 0.86 PRKACA (0.52) CAMK2DPRKACAPRKACGPRKACBSIRT2
SCHEMBL1995136 0.83 PRKACA (0.44) CAMK2DPRKACAPRKACGPRKACBSIRT2
SCHEMBL1993511 0.83 CAMK2D (0.45) CAMK2DPRKACAPRKACGPRKACBPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO CAMK2D 2963/4885PRKACA 947/4885PRKACG 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.